Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the exercise of 35,059,448 warrants, which were ...

The stock of Tenax Therapeutics has surged following a corporate update and strong KOL support for TNX-103 in PH-HFpEF. Read the latest analysis on TENX here.

While the FDA mulls whether to approve Protagonist Therapeutics’ hematology asset, the biotech is thinking it will pocket $400 million rather than split U.S. profits with its partner Takeda. | While ...

Announced positive topline results from TX45 Phase 1b acute hemodynamic clinical trial in patients with Group 2 Pulmonary Hypertension in Heart ...

Matricelf Ltd. (TASE: MTLF), a biotechnology company developing personalized regenerative therapies for spinal cord ...

Former Pentagon advisor expands the firm’s work on national security, dual-use technology, and regulatory risk facing ...

India and Israel on Thursday announced the elevation of their bilateral relationship to a "Special Strategic Partnership for Peace, Innovation and Prosperity", marking a significant expansion of ...

Study Finds Even Low Plaque Levels Raise Heart Attack Risk in WomenWomen may face a higher risk of heart attack even at lower levels of artery ...

NEWARK, CA / ACCESS Newswire / February 25, 2026 / Protagonist Therapeutics (Nasdaq:PTGX) (“Protagonist” or “the Company”) today reported financial results for the fourth quarter and full year ended ...

Prime Minister Narendra Modi and his Israeli counterpart, Benjamin Netanyahu, addressed a joint press conference on Thursday ...

Novo Nordisk (NYSE:NVO) is widely associated with therapies for chronic metabolic conditions, including diabetes and weight management. Demand drivers in this area are shaped by clinical guidelines, ...

On track for INLIGHT clinical data update in 1Q 2026; fat loss similar to GLP-1 observed at three months and expected to continue over time and ...